Abstract
A number of human PRL-secreting pituitary adenomas were tested for their in vitro responsiveness to dopamine (DA) and vasoactive intestinal polypeptide (VIP). PRL release from tumor fragments and adenylate cyclase (AC) activity in membrane fractions were evaluated. Both the hormone release and the enzyme activity were found to be inhibited by DA and stimulated by VIP. Significant differences between microadenomas (diameter less than 10 mm) and macroadenomas have been demonstrated: 1) the basal secretory activity (calculated per milligram of tissue protein) was higher in macro- than in microprolactinomas; 2) PRL release and AC activity were inhibited by a given concentration of DA to a higher extent in macro- than in microadenomas; 3) the dose-effect curves of DA both on PRL release and AC activity showed that the potency, and, in some cases, also the efficacy of the catecholamine was greater in macro- than in microadenomas; 4) PRL release and AC activity were stimulated by a given concentration of VIP to ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of clinical endocrinology and metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
